Nifty50: 17,617 ▼139 (-0.7%)
Sensex: 59,037 ▼427 (-0.7%)
- The markets opened and closed nearly at the same level, indicating indecision and a potential pause in the on-going fall
- Given the intensity of the fall in Nifty50 this week, any bounce from here would be looked at with suspicion until fresh highs are hit
- Among the Nifty sectoral indices, only FMCG (+0.3%) closed in the green. Whereas, Media (-3.4%) and PSU Bank (-3.0%) were the top losers
| Top gainers | Today's change |
| Bajaj Auto | ▲ 3.6% |
| HUL | ▲ 3.0% |
| Maruti | ▲ 1.7% |
| Top losers | Today's change |
| Bajaj Finserv | ▼ 5.0% |
| Tech Mahindra | ▼ 4.6% |
| Shree Cement | ▼ 4.5% |
For more updates on F&O, click here
Here are the top stories of the day.
Mphasis posts strong Q3 results
The IT firm’s December quarter revenue and profit stood at ₹3,124 crore and ₹358 crore, up 9% QoQ and 5% QoQ, respectively. The company bagged four large deals during the quarter, with the largest deal being $92 million.
The management said that the shift in global megatrends toward rise in technology spending is an opportunity for the company to sustain its growth momentum. Amidst broader market weakness, shares of Mphasis closed 1.1% lower.
PNB Housing Q3 profit falls
The housing finance company’s net profit dropped 19% year-on-year to ₹188 crore. In the same period, the net interest income also declined 26% to ₹439 crore due to a drop in disbursements.
Its asset quality also sharply deteriorated, falling to 7.6% of the loan book in Q3FY22 from 4.4% in Q3FY21. The management said that it continues with focus on the retail segment, which constitutes 97% of loan disbursements in the December quarter. Shares of PNB Housing Finance were down 4.9% today.
Biocon posts robust Q3 performance
The active pharmaceutical ingredient maker’s net profit rose 11% year-on-year to ₹187 crore. The growth in the bottom line was driven by a 17% rise in the revenue to ₹2,174 crore.
The company’s all divisions posted growth with the biosimilars business growing the fastest at 28%. The management sounded upbeat, saying that approvals for its generics and biosimilars in global markets and renewal of key long-term agreements put Biocon in a strong position. Shares of the company were up 3.3% today.
IPO Corner
The IPO party will continue on D-street next week. Adani Wilmar, which sells edible oil, wheat flour, rice and pulses under the brand name ‘Fortune’, will launch its IPO on 27 January 2021. The price band for the ₹3,600 crore public issue is between ₹218 and ₹230 per share. Click here to apply for the IPOs on Upstox.
Good to know
What is a Cap table?
A capitalization table(cap table) is prepared by companies and startups to show the ownership stakes in a business. The table records each investor's ownership in the company and how much they paid for it. It helps to understand the current equity structure, see the ESOP pool, and to see potential change in the structure at the time of capital raising.
Click here to join us on Telegram for trading and investment-related videos, daily market updates, details on upcoming IPOs and more.
We'd love your thoughts on this market recap.
Haven't tried out Upstox yet? Click here to open your account now!